journal
MENU ▼
Read by QxMD icon Read
search

European Journal of Health Economics: HEPAC: Health Economics in Prevention and Care

journal
https://www.readbyqxmd.com/read/29626266/preferences-for-home-and-community-based-long-term-care-services-in-germany-a-discrete-choice-experiment
#1
T Lehnert, O H Günther, A Hajek, S G Riedel-Heller, H H König
BACKGROUND: Most people prefer to "age in place" and to remain in their homes for as long as possible even in case they require long-term care. While informal care is projected to decrease in Germany, the use of home- and community-based services (HCBS) can be expected to increase in the future. Preference-based data on aspects of HCBS is needed to optimize person-centered care. OBJECTIVE: To investigate preferences for home- and community-based long-term care services packages...
April 6, 2018: European Journal of Health Economics: HEPAC: Health Economics in Prevention and Care
https://www.readbyqxmd.com/read/29574666/impact-of-increasing-treatment-rates-on-cost-effectiveness-of-subcutaneous-immunotherapy-scit-in-respiratory-allergy-a-decision-analytic-modelling-approach
#2
Ann-Kathrin Richter, Ludger Klimek, Hans F Merk, Norbert Mülleneisen, Harald Renz, Wolfgang Wehrmann, Thomas Werfel, Eckard Hamelmann, Uwe Siebert, Gaby Sroczynski, Jürgen Wasem, Janine Biermann-Stallwitz
BACKGROUND: Specific immunotherapy is the only causal treatment in respiratory allergy. Due to high treatment cost and possible severe side effects subcutaneous immunotherapy (SCIT) is not indicated in all patients. Nevertheless, reported treatment rates seem to be low. This study aims to analyze the effects of increasing treatment rates of SCIT in respiratory allergy in terms of costs and quality-adjusted life years (QALYs). METHODS: A state-transition Markov model simulates the course of disease of patients with allergic rhinitis, allergic asthma and both diseases over 10 years including a symptom-free state and death...
March 24, 2018: European Journal of Health Economics: HEPAC: Health Economics in Prevention and Care
https://www.readbyqxmd.com/read/29572758/does-freedom-make-a-difference-an-empirical-investigation-of-differences-between-subjective-well-being-and-perceived-capabilities-amongst-cancer-patients
#3
Philippe Tessier, Josselin Thuilliez
Perceived capabilities-a subjective operationalization of Sen's concept of capability-and subjective well-being are increasingly regarded as relevant information about individual well-being to guide resources allocation in healthcare. Although they refer to different notions, both types of measures rely on self-reported information and little is known as to how they compare together empirically. The aim of this paper is to investigate differences between measures of subjective well-being and of perceived capabilities in terms of their correlation with dimensions of health-related quality of life using panel data concerning a sample of 293 breast cancer and melanoma patients...
March 23, 2018: European Journal of Health Economics: HEPAC: Health Economics in Prevention and Care
https://www.readbyqxmd.com/read/29569092/the-impact-of-health-on-wages-evidence-for-europe
#4
Ana Rodriguez-Alvarez, César Rodriguez-Gutierrez
This paper analyses the effects of health on wages in sixteen European countries using production frontier methodology. It is assumed that workers have a potential income/productivity which basically depends on their human capital, but due to several health problems, situations could exist where workers fail to reach their potential income frontier. The estimation of a true-random-effects model allows us to conclude that the potential hourly wage of workers is significantly influenced by their level of education and their job experience...
March 22, 2018: European Journal of Health Economics: HEPAC: Health Economics in Prevention and Care
https://www.readbyqxmd.com/read/29564606/some-adjustments-to-the-human-capital-and-the-friction-cost-methods
#5
Antonis Targoutzidis
The cost of lost output is a major component of the total cost of illness estimates, especially those for the cost of workplace accidents and diseases. The two main methods for estimating this output, namely the human capital and the friction cost method, lead to very different results, particularly for cases of long-term absence, which makes the choice of method a critical dilemma. Two hidden assumptions, one for each method, are identified in this paper: for human capital method, the assumption that had the accident not happened the individual would remain alive, healthy and employed until retirement, and for friction cost method, the assumption that any created vacancy is covered by an unemployed person...
March 21, 2018: European Journal of Health Economics: HEPAC: Health Economics in Prevention and Care
https://www.readbyqxmd.com/read/29524005/the-cost-effectiveness-of-nivolumab-monotherapy-for-the-treatment-of-advanced-melanoma-patients-in-england
#6
Yang Meng, Nadine Hertel, John Ellis, Edith Morais, Helen Johnson, Zoe Philips, Neil Roskell, Andrew Walker, Dawn Lee
BACKGROUND: Nivolumab was the first programmed death receptor 1 (PD-1) immune checkpoint inhibitor to demonstrate long-term survival benefit in a clinical trial setting for advanced melanoma patients. OBJECTIVE: To evaluate the cost effectiveness of nivolumab monotherapy for the treatment of advanced melanoma patients in England. METHODS: A Markov state-transition model was developed to estimate the lifetime costs and benefits of nivolumab versus ipilimumab and dacarbazine for BRAF mutation-negative patients and versus ipilimumab, dabrafenib, and vemurafenib for BRAF mutation-positive patients...
March 9, 2018: European Journal of Health Economics: HEPAC: Health Economics in Prevention and Care
https://www.readbyqxmd.com/read/29520521/patient-empowerment-in-europe-is-no-further-research-needed
#7
EDITORIAL
Livio Garattini, Anna Padula
No abstract text is available yet for this article.
March 8, 2018: European Journal of Health Economics: HEPAC: Health Economics in Prevention and Care
https://www.readbyqxmd.com/read/29470673/how-much-does-the-treatment-of-each-major-disease-cost-a-decomposition-of-swiss-national-health-accounts
#8
Simon Wieser, Marco Riguzzi, Mark Pletscher, Carola A Huber, Harry Telser, Matthias Schwenkglenks
In most countries, surprisingly little is known on how national healthcare spending is distributed across diseases. Single-disease cost-of-illness studies cover only a few of the diseases affecting a population and in some cases lead to untenably large estimates. The objective of this study was to decompose healthcare spending in 2011, according to Swiss National Health Accounts, into 21 collectively exhaustive and mutually exclusive major disease categories. Diseases were classified following the Global Burden of Disease Study...
February 22, 2018: European Journal of Health Economics: HEPAC: Health Economics in Prevention and Care
https://www.readbyqxmd.com/read/29468343/authors-reply-to-gandjour-modeling-the-cost-effectiveness-of-infant-vaccination-with-pneumococcal-conjugate-vaccines-in-germany
#9
LETTER
Alexander Kuhlmann, J-Matthias Graf von der Schulenburg
No abstract text is available yet for this article.
February 21, 2018: European Journal of Health Economics: HEPAC: Health Economics in Prevention and Care
https://www.readbyqxmd.com/read/29468342/unobserved-heterogeneity-in-work-absence
#10
María José Suárez, Cristina Muñiz
Labour absenteeism may be detrimental to firms and society because of the economic costs, organizational problems and production cuts that it involves. Although involuntary absenteeism due to accident or illness that prevents workers from performing their work is unavoidable, avoidable voluntary absenteeism may also emerge due to asymmetric information given that neither employers nor doctors have perfect information about workers' health status. Assuming that there is heterogeneity in individual's behaviour and thus some workers are more likely to take sick leave than others due to differences in observable and unobservable characteristics, we specify a Finite Mixture Model to analyse sick leave days per year using a sample of employees from the 2014 European Health Survey in Spain...
February 21, 2018: European Journal of Health Economics: HEPAC: Health Economics in Prevention and Care
https://www.readbyqxmd.com/read/29464418/annual-costs-attributed-to-atrial-fibrillation-management-cross-sectional-study-of-primary-healthcare-electronic-records
#11
Marc Casajuana, Maria Giner-Soriano, Albert Roso-Llorach, Cristina Vedia, Concepció Violan, Rosa Morros
Atrial fibrillation (AF) is the most common chronic arrhythmia, with increasing healthcare and economic burden and a prevalence which increases with progressive ageing. This study aims to describe overall annual costs per patient for management of non-valvular AF in a primary healthcare (PHC) setting and compare these costs between the groups of patients treated with vitamin K antagonists, antiplatelets or non-treated through a population-based study conducted with electronic health records. We analysed annual costs per person of 19,787 patients in 2012; PHC visits, hospital admissions, AF-related events requiring hospital admission, referrals to secondary specialists, sick leave, diagnostic tests and laboratory tests at PHC level, including INR determinations performed in PHC, and drug therapy...
February 20, 2018: European Journal of Health Economics: HEPAC: Health Economics in Prevention and Care
https://www.readbyqxmd.com/read/29455374/the-earnings-and-employment-losses-before-entering-the-disability-system
#12
Maria Cervini-Pla, Judit Vall Castelló
Although a number of papers in the literature have shown the employment and wage differences between individuals receiving disability benefits and non-disabled individuals, not much is known about the potential employment and wage losses that disabled individuals suffer before being officially accepted into the disability insurance system (DI). Therefore, in this paper we compare individuals that enter into the DI system due to a progressive deterioration in the health status (ordinary illness) to similar non-disabled individuals...
February 17, 2018: European Journal of Health Economics: HEPAC: Health Economics in Prevention and Care
https://www.readbyqxmd.com/read/29453763/testing-the-grossman-model-of-medical-spending-determinants-with-macroeconomic-panel-data
#13
Jochen Hartwig, Jan-Egbert Sturm
Michael Grossman's human capital model of the demand for health has been argued to be one of the major achievements in theoretical health economics. Attempts to test this model empirically have been sparse, however, and with mixed results. These attempts so far relied on using-mostly cross-sectional-micro data from household surveys. For the first time in the literature, we bring in macroeconomic panel data for 29 OECD countries over the period 1970-2010 to test the model. To check the robustness of the results for the determinants of medical spending identified by the model, we include additional covariates in an extreme bounds analysis (EBA) framework...
February 16, 2018: European Journal of Health Economics: HEPAC: Health Economics in Prevention and Care
https://www.readbyqxmd.com/read/29445942/market-structure-and-competition-in-the-healthcare-industry-results-from-a-transition-economy
#14
Martin Lábaj, Peter Silanič, Christoph Weiss, Biliana Yontcheva
The present paper provides first empirical evidence on the relationship between market size and the number of firms in the healthcare industry for a transition economy. We estimate market-size thresholds required to support different numbers of suppliers (firms) for three occupations in the healthcare industry in a large number of distinct geographic markets in Slovakia, taking into account the spatial interaction between local markets. The empirical analysis is carried out for three time periods (1995, 2001 and 2010) which characterise different stages of the transition process...
February 14, 2018: European Journal of Health Economics: HEPAC: Health Economics in Prevention and Care
https://www.readbyqxmd.com/read/29445941/population-norms-for-the-eq-5d-3l-a-cross-country-analysis-of-population-surveys-for-20-countries
#15
M F Janssen, A Szende, J Cabases, J M Ramos-Goñi, G Vilagut, H H König
This study provides EQ-5D population norms for 20 countries (N = 163,838), which can be used to compare profiles for patients with specific conditions with data for the average person in the general population in a similar age and/or gender group. Descriptive EQ-5D data are provided for the total population, by gender and by seven age groups. Provided index values are based on European VAS for all countries, based on TTO for 11 countries and based on VAS for 10 countries. Important differences exist in EQ-5D reported health status across countries after standardizing for population structure...
February 14, 2018: European Journal of Health Economics: HEPAC: Health Economics in Prevention and Care
https://www.readbyqxmd.com/read/29411178/comment-on-modeling-the-cost-effectiveness-of-infant-vaccination-with-pneumococcal-conjugate-vaccines-in-germany
#16
LETTER
Afschin Gandjour
No abstract text is available yet for this article.
February 6, 2018: European Journal of Health Economics: HEPAC: Health Economics in Prevention and Care
https://www.readbyqxmd.com/read/29380229/how-well-do-discrete-choice-experiments-predict-health-choices-a-systematic-review-and-meta-analysis-of-external-validity
#17
Matthew Quaife, Fern Terris-Prestholt, Gian Luca Di Tanna, Peter Vickerman
Discrete choice experiments (DCEs) are economic tools that elicit the stated preferences of respondents. Because of their increasing importance in informing the design of health products and services, it is critical to understand the extent to which DCEs give reliable predictions outside of the experimental context. We systematically reviewed the literature of published DCE studies comparing predictions to choices made in reality; we extracted individual-level data to estimate a bivariate mixed-effects model of pooled sensitivity and specificity...
January 29, 2018: European Journal of Health Economics: HEPAC: Health Economics in Prevention and Care
https://www.readbyqxmd.com/read/29362900/the-effect-of-online-gambling-on-gambling-problems-and-resulting-economic-health-costs-in-germany
#18
Tobias Effertz, Anja Bischof, Hans-Jürgen Rumpf, Christian Meyer, Ulrich John
Problematic and pathological gambling have emerged as substantial problems in many countries. One potential accelerating factor for this phenomenon during recent years is the Internet, which offers different kinds of games and online applications for gambling that are faster, more attractive due to a variety of design and marketing options, less costly and potentially more addictive than terrestrial gambling opportunities. However, the contributing role of the Internet for problematic gambling has not been analyzed sufficiently so far and remains inconclusive...
January 23, 2018: European Journal of Health Economics: HEPAC: Health Economics in Prevention and Care
https://www.readbyqxmd.com/read/29362899/costs-of-dose-escalation-among-ulcerative-colitis-patients-treated-with-adalimumab-in-germany
#19
Bernadette Pöllinger, Wolfgang Schmidt, Anna Seiffert, Heidi Imhoff, Martin Emmert
AIMS: We determined adalimumab utilisation and associated drug costs in patients with ulcerative colitis (UC), focusing on patients requiring dose escalation. METHODS: The retrospective cohort study analysed the de-identified prescription data of the Arvato Health Analytics (Munich, Germany) database (2010-2015) in adult UC patients undergoing adalimumab therapy. RESULTS: A total of 154 patients were newly treated with adalimumab (average 39...
January 23, 2018: European Journal of Health Economics: HEPAC: Health Economics in Prevention and Care
https://www.readbyqxmd.com/read/29032482/the-use-of-budget-impact-analysis-in-the-economic-evaluation-of-new-medicines-in-australia-england-france-and-the-united-states-relationship-to-cost-effectiveness-analysis-and-methodological-challenges
#20
EDITORIAL
Salah Ghabri, Josephine Mauskopf
No abstract text is available yet for this article.
March 2018: European Journal of Health Economics: HEPAC: Health Economics in Prevention and Care
journal
journal
39984
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"